Severe Anemia in Papua New Guinean Children from a Malaria-Endemic Area: A Case-Control Etiologic Study

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Manning, Laurens ^a   Laman, Moses ^a,b   Rosanas Urgell, Anna ^b   Michon, Pascal ^b,c   Aipit, Susan ^b   Bona, Cathy ^b   Siba, Peter ^b   Mueller, Ivo ^b,d,e   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c Divine Word University   (Papua New Guinea)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FOLIC ACID; HEMOGLOBIN; IMMUNOGLOBULIN M; IRON;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; OBSERVATIONAL STUDY; PAPUA NEW GUINEA; PARASITE VIABILITY; PARVOVIRUS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RETICULOCYTE; RETINOL DEFICIENCY; RISK FACTOR; SCHOOL CHILD; VACCINATION;

ANEMIA; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBINS; HUMANS; INFANT; MALARIA, VIVAX; MALE; PAPUA NEW GUINEA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; VACCINATION; VITAMIN A DEFICIENCY;

EID: 84872037742     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001972     Document Type: Article

References (59)

1. Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, et al. (2008) Severe anemia in Malawian children. N Engl J Med 358: 888-899.
2. Newton CR, Warn PA, Winstanley PA, Peshu N, Snow RW, et al. (1997) Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 2: 165-178.
3. Brabin BJ, Premji Z, Verhoeff F, (2001) An analysis of anemia and child mortality. J Nutr 131: 636S-645S.
4. Lackritz EM, Hightower AW, Zucker JR, Ruebush TK 2nd, Onudi CO, et al. (1997) Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. Aids 11: 1487-1494.
5. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, et al. (2001) Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 357: 1471-1477.
6. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, et al. (1997) Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350: 844-850.
7. World Health Organisation (2006) Worldwide prevalence of anaemia 1993-2005. Geneva, Switzerland: World Health Organisation.
8. World Health Organization (1998) Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Geneva, Switzerland: World Health Organisation.
9. Wildig J, Michon P, Siba P, Mellombo M, Ura A, et al. (2006) Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 194: 146-153.
10. Calis JC, Rotteveel HP, van der Kuyl TA, Zorgdrager F, Kachala D, et al. (2008) Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children. BMC Infect Dis 8: 26.
11. von Kalckreuth V, Evans JA, Timmann C, Kuhn D, Agbenyega T, et al. (2006) Promoter polymorphism of the anion-exchange protein 1 associated with severe malarial anemia and fatality. J Infect Dis 194: 949-957.
12. Wildig J, Cossart Y, Peshu N, Gicheru N, Tuju J, et al. (2010) Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study. BMC Infect Dis 10: 88.
13. Yeats J, Daley H, Hardie D, (1999) Parvovirus B19 infection does not contribute significantly to severe anaemia in children with malaria in Malawi. Eur J Haematol 63: 276-277.
14. Bonsch C, Kempf C, Mueller I, Manning L, Laman M, et al. (2010) Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl Trop Dis 4: e669.
15. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
16. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, et al. (2001) Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 65: 614-622.
17. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997-1008.
18. Cattani JA, Tulloch JL, Vrbova H, Jolley D, Gibson FD, et al. (1986) The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am J Trop Med Hyg 35: 3-15.
19. Joint United Nations Programme on HIV/AIDS (2010) Global Report Fact Sheet- Oceania. Available: http://www.unaids.org/en/regionscountries/countries/papuanewguinea/. Accessed 2012 Aug.
20. Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, et al. (2011) Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage. PLoS Negl Trop Dis 5: e932.
21. Manning L, Laman M, Law I, Bona C, Aipit S, et al. (2011) Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One 6: e29203.
22. World Health Organization (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switzerland: World Health Organization.
23. Paediatrics Society of PNG (2005) Standard Treatment for common illnesses of children in PNG. 8th edition.
24. World Health Organisation (2009) AnthroPlus for personal computers manual: Software for assessing growth of the world's children and adolescents. Geneva, Switzerland: World Health Organisation.
25. Shann F, Biddulph J, Vince J (2003) Paediatrics for Doctors in Papua New Guinea. Port Moresby, Papua New Guinea: Department of Health.
26. Imrie H, Fowkes FJ, Michon P, Tavul L, Hume JC, et al. (2006) Haptoglobin levels are associated with haptoglobin genotype and alpha+-Thalassemia in a malaria-endemic area. Am J Trop Med Hyg 74: 965-971.
27. Jarolim P, Palek J, Amato D, Hassan K, Sapak P, et al. (1991) Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA 88: 11022-11026.
28. Tavul L, Mueller I, Rare L, Lin E, Zimmerman PA, et al. (2008) Glycophorin C delta(exon3) is not associated with protection against severe anaemia in Papua New Guinea. PNG Med J 51: 149-154.
29. Xiang L, Rundles JR, Hamilton DR, Wilson JG, (1999) Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 163: 4939-4945.
30. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing.
31. Rubin D (1987) Multiple imputation for nonresponse in surveys. New York: Wiley.
32. Honaker J, King G, Blackwell M (2010) Amelia II: A Program for Missing Data.
33. Raemsch C (2010) pARccs: Estimation of attributable and partial attributable risks (AR and PAR) and visualization of attributable risks from case-control data. Available: http://CRAN.R-project.org/package=pARccs. Accessed 2012 Aug.
34. Raemsch C, Pfahlberg AB, Gefeller O, (2009) Point and interval estimation of partial attributable risks from case-control data using the R-package 'pARccs'. Comput Methods Programs Biomed 94: 88-95.
35. Abshire TC, (1996) The anemia of inflammation. A common cause of childhood anemia. Pediatr Clin North Am 43: 623-637.
36. Fishman SM, Christian P, West KP, (2000) The role of vitamins in the prevention and control of anaemia. Public Health Nutr 3: 125-150.
37. Sanjoaquin MA, Molyneux ME, (2009) Malaria and vitamin A deficiency in African children: a vicious circle? Malar J 8: 134.
38. Semba RD, Bloem MW, (2002) The anemia of vitamin A deficiency: epidemiology and pathogenesis. Eur J Clin Nutr 56: 271-281.
39. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, et al. (2010) Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS One 5: e9047.
40. Mueller I, Widmer S, Michel D, Maraga S, McNamara DT, et al. (2009) High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea. Malar J 8: 41.
41. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, et al. (2009) Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis 48: 1704-1712.
42. Shander A, (2004) Anemia in the critically ill. Crit Care Clin 20: 159-178.
43. Corwin HL, Krantz SB, (2000) Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med 28: 3098-3099.
44. Haldar K, Mohandas N, (2009) Malaria, erythrocytic infection, and anemia. Hematology Am Soc Hematol Educ Program pp. 87-93.
45. McElroy PD, ter Kuile FO, Lal AA, Bloland PB, Hawley WA, et al. (2000) Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg 62: 504-512.
46. Maitland K, Williams TN, Bennett S, Newbold CI, Peto TE, et al. (1996) The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 90: 614-620.
47. Stanisic DI, Mueller I, Betuela I, Siba P, Schofield L, (2010) Robert Koch redux: malaria immunology in Papua New Guinea. Parasite Immunol 32: 623-632.
48. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, et al. (1997) The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 91: 256-262.
49. Maitland K, Williams TN, Newbold CI, (1997) Plasmodium vivax and P. falciparum: Biological interactions and the possibility of cross-species immunity. Parasitology today 13: 227-231.
50. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, et al. (2000) Cross-species interactions between malaria parasites in humans. Science 287: 845-848.
51. Schofield L, Mueller I, (2006) Clinical immunity to malaria. Curr Mol Med 6: 205-221.
52. Helleberg M, Goka BQ, Akanmori BD, Obeng-Adjei G, Rodriques O, et al. (2005) Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia. Malar J 4: 56.
53. Burgmann H, Looareesuwan S, Kapiotis S, Viravan C, Vanijanonta S, et al. (1996) Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg 54: 280-283.
54. Grasbeck R, (2004) The evolution of the reference value concept. Clin Chem Lab Med 42: 692-697.
55. Shankar AH, Genton B, Semba RD, Baisor M, Paino J, et al. (1999) Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet 354: 203-209.
56. Zeba AN, Sorgho H, Rouamba N, Zongo I, Rouamba J, et al. (2008) Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial. Nutr J 7: 7.
57. Benn CS, Martins C, Rodrigues A, Jensen H, Lisse IM, et al. (2005) Randomised study of effect of different doses of vitamin A on childhood morbidity and mortality. BMJ 331: 1428-1432.
58. Glasziou PP, Mackerras DE, (1993) Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 306: 366-370.
59. Senn N, Rarau P, Stanisic DI, Robinson L, Barnadas C, et al. (2012) Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLoS Med 9: e1001195.